• Study of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease

    Not yet recruiting

    2 1
    France Germany The Netherlands Spain
  • Targeted peri‑operative prophylaxis using eravacycline (drug combination) versus standard prophylaxis in liver transplant patients colonized with CPE

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Fluorescence bronchoscopy to assess durvalumab-680LT distribution in unresectable stage III non‑small cell lung cancer patients after chemoradiation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Phase 2 Study of Safety and Efficacy of PF-08634404 Alone or with Drug Combination in Adults with Early-Stage or Locally Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    France Germany Ireland Italy Poland Spain
  • Safety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany Italy The Netherlands Spain
  • Oral bioavailability and tolerability of hydrocortisone tablets vs hydrocortisone sodium phosphate orodispersible films in children and adolescents with adrenal insufficiency

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Germany
  • Dapagliflozin for Primary Cardioprotection in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation – A Randomized Phase 2 Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Intravenous benzathine benzylpenicillin added to oral phenoxymethylpenicillin for relief in adults with acute tonsillitis, peritonsillar phlegmon and abscess

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Denmark
  • Effect of estradiol‑based menopausal hormone therapy drug combination on QTc in peri‑ and postmenopausal women with genetically confirmed Long QT syndrome

    Not yet recruiting

    3 1 1 1
    Norway
  • Azenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer

    Not yet recruiting

    3 1 1 1
    Belgium France Germany Ireland Italy Poland +1

powered by